Steven A. Shallcross, CEO and CFO: Theriva Biologics TOVX Buy · Filed 23/02/13

Trade details

Type: Insider buy
Amount: $26,000
Shares · price: 25,000 sh · $1.04 a share
Held after: 210,000 sh
Stock: Theriva Biologics TOVX
Person: Steven A. ShallcrossCEO and CFO
Trade date: 23/02/10
Filed: 23/02/13
Days to filing: 3 days

Holdings up 13.5%

Insiders buying this week: 1 insiders
Holding change: +13.5%

Theriva Biologics trades, last 26 weeks

What else happened in Theriva Biologics around then

Filed or reported within 30 days of the trade day · 23/01/11~23/03/12

Steven A. Shallcross's recent trades

Steven A. ShallcrossCEO and CFO
BuyTheriva Biologics
Buy
Theriva Biologics
TOVX
$9,660
14,000 sh
$9,660
Filed 23/06/08
Traded 23/06/07
Steven A. ShallcrossCEO and CFO
BuyTheriva Biologics
Buy
Theriva Biologics
TOVX
$16.4K
26,000 sh
$16.4K
Filed 23/06/07
Traded 23/06/06
Steven A. ShallcrossCEO and CFO
BuyTheriva Biologics
Buy
Theriva Biologics
TOVX
$23.5K
25,000 sh
$23.5K
Filed 23/02/03
Traded 23/02/02
Steven A. ShallcrossCEO and CFO
BuyTheriva Biologics
Buy
Theriva Biologics
TOVX
$21.8K
25,000 sh
$21.8K
Filed 23/01/26
Traded 23/01/25
Steven A. ShallcrossCEO and CFO
BuyTheriva Biologics
Buy
Theriva Biologics
TOVX
$18.8K
25,000 sh
$18.8K
Filed 23/01/23
Traded 23/01/20

Steven A. Shallcross, CEO — bought $26K of Theriva Biologics TOVX · 25,000 sh @ $1.04 | Whalegun